CABOMETYX
Identification of Cabometyx
| No description |
Google image searchProduct monograph
Active ingredient
cabozantinib (cabozantinib malate), 40 MG
DIN: 02480832
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: IPSEN BIOPHARMACEUTICALS CANADA INC
Date: 10-OCT-2018
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX07 — CABOZANTINIB (ATC/DDD)
